Which cancers do PETCT check for in the head

PET-CT examination can be used to diagnose various head lesions of cancer, mainly including malignant tumors such as glioma, nasopharyngeal carcinoma, head and neck squamous cell carcinoma, brain metastases, pituitary tumors, etc.

1. Gliomas

PET-CT can help differentiate the malignancy of gliomas by displaying the glucose metabolism activity of tumor tissue. Low grade gliomas typically exhibit mild metabolic elevation, while high-grade gliomas such as glioblastoma show significant metabolic elevation. Fasting for 4-6 hours is required before the examination, followed by injection of fluorodeoxyglucose and resting for 45-60 minutes. This examination can assist in determining the tumor boundary and provide localization basis for surgery or radiotherapy.

2. Nasopharyngeal carcinoma

Nasopharyngeal carcinoma is characterized by asymmetric high metabolism lesions in the nasopharynx during PET-CT, which has an advantage in early detection of submucosal lesions. Examination can simultaneously evaluate the status of cervical lymph node metastasis, typically manifested as a significant increase in standardized uptake values. For monitoring recurrence after radiotherapy, PET-CT is more sensitive than conventional imaging and can distinguish between post-treatment fibrosis and tumor residue.

3. Head and neck squamous cell carcinoma

Oral cancer, laryngeal cancer and other nasopharyngeal tumors show focal radioactive concentration in PET-CT, which helps to detect cervical lymph node metastases with unknown primary lesions. The detection rate of bone invasion by examination is better than that of CT, which can avoid misjudgment of benign lesions such as osteomyelitis. PET-CT can more accurately delineate the tumor target area for radiotherapy planning.

4. Brain metastases

Brain metastases from lung cancer, breast cancer and other malignant tumors show multiple hypermetabolic nodules on PET-CT, which are common in the gray white matter junction area. The detection rate of small metastases can reach 5 millimeters, which is better than enhanced MRI. Melanoma brain metastasis may exhibit characteristic high metabolism, while prostate cancer brain metastasis may have lower metabolism.

5. Pituitary Tumors

Functional pituitary adenomas such as growth hormone tumors show abnormally high metabolism in the pituitary region during PET-CT, while non functional adenomas often have normal metabolism. Examination has value in distinguishing the recurrence of pituitary cancer, and the recurrent lesions are usually characterized by progressive metabolic elevation. For postoperative evaluation, PET-CT can distinguish surgical scars from residual tumor tissue.

Metal objects shall be removed before PET-CT examination of the head, and blood sugar level of diabetes patients shall be adjusted. After the examination, it is recommended to drink more water to promote the excretion of imaging agents and avoid close contact with pregnant women and children within 24 hours. For suspected malignant tumor patients, it is recommended to combine enhanced MRI or biopsy for comprehensive judgment. Regular follow-up can help monitor treatment effectiveness and detect recurrence early.